Option chain shows key data for Bone Biologics's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Bone Biologics.

Bone Biologics (NASDAQ:BBLG) Stock, Option Chain

Bone Biologics

Bone Biologics Corp is a healthcare solutions provider based in the United States. As a biotechnology firm, it engages its efforts in developing therapeutics to aid bone regeneration. The company's portfolio comprises its lead product, NELL-1, which is a bone void filler. Bone Biologics' technology has applications in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine.

Market Up

News

Health Care

Financing

Offerings

Movers

Trading Ideas

General

BBLG

Bone Biologics filed a USPTO patent for NELL-1 and announced a $5 million offering to support trials and expand its bone regeneration patent portfolio.

Why Is Bone Biologics Stock Surging On Friday?

movers image

Pre-Market Outlook

Markets

ADGM

ALLR

APVO

AVGR

CNEY

DRMA

GDHG

GLMD

HCWC

INTC

MYNA

NCPL

NKGN

OPTT

SMSI

SPRC

TNON

WHLR

ZVSA

Why Intel Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket

Screenshot 2024-09-16 at 5.51.32 PM

Earnings

Equities

Eurozone

Commodities

IMMP

NCNA

NWTN

Dow Jumps Over 200 Points; NY Empire State Manufacturing Index Increases In September

Bone Biologics Corp

Press Releases

Actinium Pharmaceuticals (ATNM) Unveils Promising Advances in Targeted Radiotherapies for Cancer Treatment

Bone Biologics Announces Exercise of Warrants for $2.1 Million Gross Proceeds

Bone Biologics Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Bone Biologics Appoints Phillip T. Meikle to its Board of Directors

Bone Biologics Announces 1-for-6 Reverse Stock Split

Bone Biologics Regains Compliance with Nasdaq Continued Listing Requirements

Bone Biologics Files Patent Application for Bone Regeneration Technology

Bone Biologics Announces Pricing of $5.0 Million Public Offering

ATNM

BBLGW

NUZE

PIRS

Aditxt

Alzamend Neuro

Aptevo Therapeutics

AquaBounty Technologies, Inc. - Common Stock

AquaBounty Techs

Biodexa Pharmaceuticals plc - American Depositary Shares

Biodexa Pharmaceuticals

Entero Therapeutics

GRI Bio

Lixte Biotechnology Holdings, Inc. - Common Stock

Lixte Biotechnology

Oragenics

Onconetix

Psyence Biomedical Ltd. - Ordinary Shares

Psyence Biomedical

Qualigen Therapeutics, Inc. - Common Stock

Qualigen Therapeutics

Revelation Biosciences, Inc. - Common Stock

Revelation Biosciences

Scinai Immunotherapeutics Ltd. - American Depositary Shares

Scinai Immunotherapeutics

Salarius Pharmaceuticals, Inc. - Common Stock

Salarius Pharmaceuticals

Windtree Therapeutics, Inc. - Common Stock

Windtree Therapeutics

Longevity Health Holdings, Inc. - Common Stock

Longevity Health Holdings

ZyVersa Therapeutics, Inc. - Common Stock

ZyVersa Therapeutics

EF Hutton

Comments

Bone Biologics

Bone Biologics (BBLG) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell